Cargando…
Navigating the Rapids: The Development of Regulated Next-Generation Sequencing-Based Clinical Trial Assays and Companion Diagnostics
Over the past decade, next-generation sequencing (NGS) technology has experienced meteoric growth in the aspects of platform, technology, and supporting bioinformatics development allowing its widespread and rapid uptake in research settings. More recently, NGS-based genomic data have been exploited...
Autores principales: | Pant, Saumya, Weiner, Russell, Marton, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029014/ https://www.ncbi.nlm.nih.gov/pubmed/24860780 http://dx.doi.org/10.3389/fonc.2014.00078 |
Ejemplares similares
-
Editorial: Next Generation Sequencing Based Diagnostic Approaches in Clinical Oncology
por: Buzdin, Anton, et al.
Publicado: (2021) -
In situ Protein Detection for Companion Diagnostics
por: Gremel, Gabriela, et al.
Publicado: (2013) -
Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics
por: Yang, Emily Y., et al.
Publicado: (2020) -
Next-Generation Sequencing of Disseminated Tumor Cells
por: Møller, Elen K., et al.
Publicado: (2013) -
Companion Diagnostics for Targeted Cancer Drugs – Clinical and Regulatory Aspects
por: Olsen, Dana, et al.
Publicado: (2014)